Diagnostics (Mar 2021)

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression

  • Lena M. Mittlmeier,
  • Stephan T. Ledderose,
  • Melanie Schott,
  • Matthias Brendel,
  • Leonie Beyer,
  • Sebastian Theurich,
  • Doris Mayr,
  • Christoph Walz,
  • Wolfgang G. Kunz,
  • Jens Ricke,
  • Peter Bartenstein,
  • Harun Ilhan,
  • Michael Staehler,
  • Marcus Unterrainer

DOI
https://doi.org/10.3390/diagnostics11030423
Journal volume & issue
Vol. 11, no. 3
p. 423

Abstract

Read online

We present a 71-year-old female patient who underwent 18F-PSMA-1007 PET/CT for suspected metastatic renal cell carcinoma (RCC), as RCC also shows high PSMA-expression in tumor neovascularization. 18F-PSMA-1007 PET/CT showed a high PSMA-avidity in the renal tumor, enlarged intra-abdominal and mediastinal lymph nodes. Moreover, PSMA-positive pleural, pulmonal and osseous lesions were found. However, histopathology revealed an immature plasma cell myeloma with an endothelial PSMA-expression of the neovasculature. This case illustrates the increased PSMA-avidity in multiple myeloma and highlights PSMA as a potential theragnostic target in multiple myeloma. For clinical routine, lymphatic diseases such as extramedullary myeloma should be considered as differential diagnosis in PSMA-avid renal masses on PET/CT.

Keywords